Relevium Technologies Inc
XTSX:RLV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of RLV.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| FR |
|
L'Oreal SA
PAR:OR
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
|
| JP |
|
Kao Corp
TSE:4452
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
|
| IN |
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Relevium’s multiple pivots between cannabis and nutraceutical markets risk diluting its brand identity, potentially confusing consumers and complicating market positioning efforts.
The company’s historic reliance on external financing and limited available capital could constrain R&D investment and hamper scalable growth, leaving it vulnerable if funding sources dry up.
Regulatory hurdles in both the cannabis and nutraceutical sectors—along with shifting compliance standards—could create additional costs and delays, eroding margins and weakening investor confidence.
Relevium’s targeted M&A strategy focusing on high-growth Health & Wellness segments could bolster brand strength and accelerate market penetration if post-acquisition integrations are managed effectively.
By cultivating a direct-to-consumer e-commerce model and building out proprietary product lines, the company stands to capture higher margins and strengthen its global footprint in online health sales.
The growing consumer shift toward preventative healthcare supports demand for Relevium’s functional supplements, providing a favorable industry tailwind that could drive sustained revenue expansion.
Revenue & Expenses Breakdown
Relevium Technologies Inc
Balance Sheet Decomposition
Relevium Technologies Inc
| Current Assets | 2.4m |
| Cash & Short-Term Investments | 586.3k |
| Receivables | 1.7m |
| Other Current Assets | 148.6k |
| Non-Current Assets | 577.3k |
| PP&E | 2.5k |
| Intangibles | 574.8k |
| Current Liabilities | 4.1m |
| Accounts Payable | 1.5m |
| Short-Term Debt | 1.2m |
| Other Current Liabilities | 1.4m |
| Non-Current Liabilities | 48.3k |
| Other Non-Current Liabilities | 48.3k |
Free Cash Flow Analysis
Relevium Technologies Inc
| CAD | |
| Free Cash Flow | CAD |
Earnings Waterfall
Relevium Technologies Inc
|
Revenue
|
14.2m
CAD
|
|
Cost of Revenue
|
-11.8m
CAD
|
|
Gross Profit
|
2.5m
CAD
|
|
Operating Expenses
|
-4.4m
CAD
|
|
Operating Income
|
-1.9m
CAD
|
|
Other Expenses
|
-719.4k
CAD
|
|
Net Income
|
-2.6m
CAD
|
RLV Profitability Score
Profitability Due Diligence
Relevium Technologies Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Relevium Technologies Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
RLV Solvency Score
Solvency Due Diligence
Relevium Technologies Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Relevium Technologies Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RLV Price Targets Summary
Relevium Technologies Inc
Dividends
Current shareholder yield for
RLV is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?